Table 2.

 Recipient data (preoperative and intraoperative)

Series No	Age	Diagnosis	Date of surgery	Preoperative medication	Donor eye No	Type of surgery	Course of surgery	Type and No of suture	Subcutaneous injection	Culture from media in OT
1	5/F	CHED	28.6.03	0.3% ciprofloxacin four times daily	1	Optical PK (figs 1, 2)	Uneventful	10.0 MFN 16, interrupted	Dexamethasone and gentamicin	Pseudomonas sensitive to poly B
2	17/F	Keratoconus	30.8.03	0.3% ciprofloxacin four times daily	2	DLK	Uneventful	10.0 MFN 16, interrupted	Dexamethasone and gentamicin	Not sent
3	46/M	Leucomatous corneal opacity	7.11.03	0.3% ciprofloxacin four times daily	3	Optical PK	Uneventful	10.0 MFN 16, interrupted	Dexamethasone and gentamicin	Not sent
4	65/F	Fuchs’ endothelial dystrophy	7.4.04	0.3% ciprofloxacin four times daily	4*	Triple procedure	Uneventful	10.0 MFN 16, interrupted	Dexamethasone and gentamicin	Pseudomonas sensitive to poly B
5	39/F	Post-pterygium surgery, scleral melting	7.4.04	0.3% ciprofloxacin four times daily	4*	Scleral patch graft	Uneventful	10.0 MFN interrupted 5, 8-0 Vicryl scleral suture 6	Dexamethasone and gentamicin	Pseudomonas sensitive to poly B
6	50/M	Leucomatous corneal opacity	21.4.04	0.3% ciprofloxacin four times daily	5A	Triple procedure	Uneventful	10-0 MFN 16 interrupted	Dexamethasone and gentamicin	Not sent
7	55/M	Leucomatous corneal opacity	21.4.04	0.3% ciprofloxacin four times daily	5B	Optical PK	Uneventful	10.0 MFN 16, interrupted	Dexamethasone and gentamicin	Not sent

CHED, congenital hereditary endothelial dystrophy; PK, penetrating keratoplasty; OT, operating theatre; poly B, polymyxin B.